#NACFC2021 – Phage Therapy, Now in Trial, Weakens Resistant Bacteria

#NACFC2021 – Phage Therapy, Now in Trial, Weakens Resistant Bacteria

311576

#NACFC2021 – Phage Therapy, Now in Trial, Weakens Resistant Bacteria

Personalized treatment with bacteria-infecting viruses, called bacteriophages, could be used to combat Pseudomonas aeruginosa, the main bacteria involved in lung infections in people with cystic fibrosis (CF), both by killing the bacteria and making them less resistant to antibiotics. Bacteriophage therapy “is safe, decreases P. aeruginosa titers [levels], and improves lung function,” according to researchers at Yale University, who presented results of its use at the 2021 North American Cystic Fibrosis Conference (NACFC). Their talk was…

You must be logged in to read/download the full post.